ALN Surgical Implants

What ALN Surgical Implants does

ALN Surgical Implants (ALN Implants chirurgicaux) is a privately-held French medical device manufacturer founded in 1991 that designs, produces, and distributes implantable vena cava filters and complementary extraction/repositioning kits used to prevent pulmonary embolism. The company is headquartered in Bormes-les-Mimosas (Var department, Provence-Alpes-Côte d'Azur) with a second facility in Thyez (Haute-Savoie), and operates in over 30 countries through a hybrid model combining direct sales teams with a network of trained international distributors. ALN's proprietary technology centers on optional (permanent and/or retrievable) vena cava filters manufactured from 316 LVM stainless steel without welding points, MRI conditional 3T compatible, with multiple implantation approaches (femoral, jugular, brachial, popliteal) and documented retrievability out to 12 years; the 2021 OATF filter added anti-tilting legs and loop-based anchoring to address tilt and transfixion risk.

The product portfolio comprises the original ALN Optional Vena Cava Filter (with and without hook), the 2021 ALN OATF Optional Vena Cava Filter, and three extraction/repositioning kit references (Straight RS, Pre-Curved RS, and 2in1 RS) that cover varying filter head orientations and clinical scenarios. The company serves public and private hospitals worldwide, with interventional radiologists and vascular surgeons as the primary clinical users. ALN holds cross-jurisdictional regulatory clearances including ISO 13485, EU MDR 2017/745, FDA 21 CFR Part 820, and Directive 93/42/EEC, and supports its commercial positioning with peer-reviewed clinical evidence (e.g., the Pellerin et al. study on retrieval at a mean of 25.6 months) and participation in international endovascular congresses including SIR. The company does not disclose pricing publicly and operates a healthcare-professional-only website; no app, API, or software product surface exists.

Name

ALN Surgical Implants

Legal name

ALN Implants chirurgicaux

Website

https://aln2b.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

ALN Surgical Implants is a privately-held French medical device manufacturer, founded 1991, that designs and distributes optional vena cava filters and extraction kits for pulmonary embolism prevention, serving hospitals and interventional radiology specialists worldwide through direct sales and trained distributors.

Ownership category

akta.pro rank

Product category

Vena Cava Filters (Medical Devices)

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts (HLAHAFAF)

Keywords

• Vena cava filters
• Pulmonary embolism prevention
• Medical device manufacturing
• Interventional radiology devices
• Vascular surgery implants

Headquarters

HQ city

Bormes-les-mimosas

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Device Sales - Vena Cava Filters: ALN generates revenue from the manufacturing and distribution of vena cava filters (optional/permanent and temporary) and extraction/repositioning kits. Products are sold to healthcare facilities (public and private hospitals) via direct sales teams and a distributor network. The company operates internationally, selling in France and worldwide.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

ALN Implants chirurgicaux manufactures and globally distributes optional (permanent and/or temporary) vena cava filters and a family of extraction/repositioning kits used to prevent pulmonary embolism. The filters are made from proprietary 316 LVM stainless steel without welding points and are MRI-conditional 3T compatible, with multiple implantation approaches (femoral, jugular, brachial, popliteal) and documented retrievability up to 12 years.

Differentiator

Problem solved

Functional benefit

Brands

• ALN Optional Vena Cava Filter: Permanent and/or temporary vena cava filter in 316LVM stainless steel without welding points, with 4 implantation approaches
• ALN OATF Vena Cava Filter
• ALN Extraction/Repositioning Kits

Products and services

• ALN Optional Vena Cava Filter (with and without hook) Optional permanent and/or temporary vena cava filter made of 316 LVM stainless steel without welding points, featuring 6 anchoring legs and 3 centering legs of different lengths, MRI-conditional 3T compatible, approved for vena cava up to 32 mm diameter, with 4 implantation approaches (femoral, jugular, brachial, popliteal), 7F implantation catheter, 9F removal catheter, and 12-year documented retrievability. For interventional radiologists and vascular surgeons in public and private hospitals.
• ALN OATF Optional Vena Cava Filter (with and without hook) Optional 316 LVM stainless steel vena cava filter without welding points, MRI-conditional 3T compatible, featuring 6 anchoring legs with loop system to minimize transfixion risk, 3 centering legs, and 3 anti-tilting legs for maximum centering and reduced tilt risk, approved for vena cava up to 32 mm diameter with 4 implantation approaches. For interventional radiologists and vascular surgeons seeking reinforced stability in newer-generation filtration devices.
• ALN Extraction and/or Repositioning Kits (Straight RS, Pre-Curved RS, 2in1 RS) Three kit references for removal and/or repositioning of ALN vena cava filters — ALN Straight RS for filters where head is in lower vena cava axis, ALN Pre-Curved RS for tilted filter heads, and ALN 2in1 RS with adjustable clamp angulation — made of 316 LVM stainless steel with an 8-strand clamp of varying lengths, compatible with all ALN filter references, used via jugular approach with a 9F introducer sheath. For interventional radiologists and vascular surgeons retrieving ALN vena cava filters.

Quantifiable outcome

• 12-year filter withdrawal documented
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• SÒ ADDICTEminorImplementation/ SI/ Consulting PartnerSÒ ADDICTE is the design, integration, and functionality partner responsible for the ALN Implants website (aln2b.com). Based in Taglio Isolaccio, France (Corsica), SÒ ADDICTE handles web design, integration, and development services for the company's digital presence.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Cook Medical: Cook Medical manufactures the Celect and Tulip vena cava filters, the most established retrievable filter franchises globally. It directly competes with ALN in the optional IVC filter category serving interventional radiologists and vascular surgeons.
• Cordis (Cardinal Health): Cordis offers the OptEase retrievable vena cava filter. It is a direct competitor to ALN in the IVC filter market, with overlapping interventional radiology and vascular surgery customers.
• Becton Dickinson (BD): BD acquired C.R. Bard, whose Denali and Meridian retrievable vena cava filters are among the most widely used IVC filters in the U.S. It competes head-to-head with ALN in both permanent and optional filter segments.
• Argon Medical Devices: Argon Medical manufactures the Option and Option Elite retrievable vena cava filters. It directly competes with ALN in the optional/retrievable IVC filter category globally.
• Boston Scientific: Boston Scientific markets the Greenfield Vena Cava Filter, one of the longest-standing IVC filter franchises. It is a direct competitor to ALN in the cardiovascular implant space serving similar hospital customers.

Broad incumbents

• Stryker: Stryker's neurovascular and interventional portfolio (including its IVC filter franchise) overlaps with ALN's clinical applications. As a broad medical device incumbent, it offers comparable endovascular implant solutions as part of a much larger product portfolio.

Regional players

• Mermaid Medical: Mermaid Medical distributes interventional vascular devices across European and Asian markets. While not a direct ALN competitor in manufacturing, it operates in overlapping distribution channels for IVC filters in regions where ALN relies on distributor partners.

Emerging players

• Adient Medical: Adient Medical is developing next-generation IVC filter technology with a focus on improved retrievability. As a smaller, emerging entrant, it competes with ALN in the optional filter niche with a differentiated design approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/8314049/admin

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ALN Surgical Implants